Protein Kinase C Masks Nitric Oxide Synthase Activity in Vascular Smooth Muscle under Basal Conditions

Journal of Cardiovascular Pharmacology

Volumn 43, Issue 2, 2004, Pages 281-287

  Kline, Loren W ^a   Ji, Junzhi ^a   Wang, Guei Jane ^b   Sutherland, Sharla K ^a   Pang, Peter K T ^a   Benishin, Christina G ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b NATIONAL RESEARCH INSTITUTE OF CHINESE MEDICINE   (Taiwan)

Author keywords

Nitric oxide; Nitric oxide synthase; Protein kinase C; Vascular smooth muscle

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; AMINOGUANIDINE; ARGININE; BISINDOLYLMALEIMIDE; CALPHOSTIN C; DEXTRO ARGININE; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; N(G) NITROARGININE; NITRIC OXIDE SYNTHASE; PHENYLEPHRINE; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR;

ANIMAL TISSUE; AORTA; ARTERY ENDOTHELIUM; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME INHIBITION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR SMOOTH MUSCLE;

ANIMALS; ENZYME INHIBITORS; MALE; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROARGININE; PROTEIN KINASE C; RATS; RATS, SPRAGUE-DAWLEY; VASOCONSTRICTION;

EID: 1642500094     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200402000-00018     Document Type: Article

References (31)

1. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathology and pharmacology. Pharmacol Rev. 1991;43:109-142.
2. Palmer RMJ, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature. 1988;333:664-666.
3. Förstermann U, Closs EI, Pollock JS, et al. Nitric oxide synthase isozymes: characterization, purification, molecular cloning, and functions. Hypertension. 1994;23:1121-1131.
4. Durante W, Kroll MH, Orloff GJ, et al. Regulation of interleukin-1 beta-stimulated inducible nitric oxide synthase expression in cultured vascular smooth muscle cells by hemostatic proteins. Biochem Pharmacol. 1996; 51:847-853.
5. Kanno K, Hirata Y, Imai T, et al. Induction of nitric oxide synthase gene by interleukin in vascular smooth muscle cells. Hypertension. 1993;22: 34-39.
6. Nakayama DK, Geller DA, Lowenstein CJ, et al. Cytokines and lipopolysaccharide induce nitric oxide synthase in cultured rat pulmonary artery smooth muscle. Am J Respir Cell Mol Biol. 1992;7:471-476.
7. Junquero DC, Schini VB, Scott-Burden T, et al. Enhanced production of nitric oxide in aortae from spontaneously hypertensive rats by interleukin-1β. Am J Hypertens. 1993;6:602-610.
8. Rees DD, Cellek S, Palmer RMJ, et al. Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the associated effects on vascular tone: an insight into endotoxin shock. Biochem Biophys Res Commun. 1990;173:541-547.
9. Bernhardt J, Tschudi MR, Dohi Y, et al. Release of nitric oxide from human vascular smooth muscle cells. Biochem Biophys Res Commun. 1991;180:907-912.
10. Zehetgruber M, Conforto A, Bing RJ. Vascular smooth muscle and nitric oxide. Life Sci. 1993;52:1397-1406.
11. Brophy CM, Knoepp L, Xin JD, et al. Functional expression of NOS 1 in vascular smooth muscle. Am J Physiol. 2000;278:H991-H997.
12. Maiese K, Boniece IR, Skurat K, et al. Protein kinases modulate the sensitivity of hippocampal neurons to nitric oxide toxicity and anoxia. J Neurosci Res. 1993;36:77-87.
13. Hirata K, Kuroda R, Sakoda T, et al. Inhibition of endothelial nitric oxide synthase activity by protein kinase C. Hypertension. 1995;25:180-185.
14. Murthy KS, Jin JG, Makhlouf GM. Inhibition of nitric oxide synthase activity in dispersed gastric muscle cells by protein kinase C. Am J Physiol. 1994;266:G161-G165.
15. Muniyappa R, Srinivas PR, Ram JL, et al. Calcium and protein kinase C mediate high-glucose-induced inhibition of inducible nitric oxide synthase in vascular smooth muscle cells. Hypertension. 1998;31: 289-295.
16. Yamamoto K, Ikeda U, Okada K, et al. Arginine vasopressin inhibits nitric oxide synthesis in cytokine-stimulated vascular smooth muscle cells. Hypertens Res. 1997;20:209-216.
17. Wang GJ, Wu XC, Chen CF, et al. Vasorelaxing action of rutaecarpine: effects of rutaecarpine on calcium channel activities in vascular endothelial and smooth muscle cells. J Pharmacol Exp Ther. 1999;289:1237-1244.
18. Rüegg UT, Burgess GM. Staurosporine, K-252 and UCN-01: potent but not non-specific inhibitors of protein kinase. TIPS. 1989; 10:218-220.
19. Shimamoto Y, Shimamoto H, Kwan CY, et al. Differential effects of putative protein kinase C inhibitors on contraction of rat aortic smooth muscle. Am J Physiol. 1993;264:H1300-H1306.
20. G-nitro-L-arginine, and aminoguanidine on constitutive and inducible nitric oxide synthase in rat aorta. Biochem Biophys Res Commun. 1994;199: 147-154.
21. Bredt DS, Snyder SH. Nitric oxide: a physiologic messenger molecule. Ann Rev Biochem. 1994;63:175-195.
22. Bredt DS, Ferris CD, Snyder SH. Nitric oxide synthase regulatory sites. Phosphorylation by cyclic AMP-dependent protein kinase, protein kinase C, and calcium/calmodulin protein kinase; identification of flavin and calmodulin binding sites. J Biol Chem. 1992;267:10976-10981.
23. Lewis MJ, Henderson AH. A phorbol ester inhibits the release of endothelium-derived relaxing factor. Eur J Pharmacol. 1987;137:167-171.
24. Akimoto T, Kusano E, Muto S, et al. The effect of erythropoietin on interleukin-1beta mediated increase in nitric oxide synthesis in vascular smooth muscle cells. J Hypertension. 1999; 17:1249-1256.
25. Li S, Huang FL, Feng Q, et al. Overexpression of protein kinase C alpha enhances lipopolysaccharide-induced nitric oxide formation in vascular smooth muscle cells. J Cell Physiol. 1998; 176:402-411.
26. Baydoun AR, Wileman SM, Wheeler-Jones CP, et al. Transmembrane signalling mechanisms regulating expression of cationic amino acid transporters and inducible nitric oxide synthase in rat vascular smooth muscle cells. Biochem J. 1999;344:265-272.
27. Paul A, Doherty K, Plevin R. Differential regulation by protein kinase C isoforms of nitric oxide synthase induction in RAW 264.7 macrophages and rat aortic smooth muscle cells. Br J Pharmacol. 1997;120: 940-946.
28. Arias JM, Betz H, El Far O. PKC phosphorylation of a conserved serine residue in the C-terminus of group III metabotropic glutamate receptors inhibits calmodulin binding. FEBS Lett. 2001;494:60-63.
29. Griffiths MJD, Messent M, MacAllister RJ, et al. Aminoguanidine selectively inhibits inducible nitric oxide synthase. Br J Pharmacol. 1993;110: 963-968.
30. Marczin N, Ryan US, Catravas JD. Methylene blue inhibits nitrovasodilator- and endothelium-derived relaxing factor-induced cyclic GMP accumulation in cultured pulmonary arterial smooth muscle cells via generation of superoxide anion. J Pharmacol Exp Ther. 1992;263: 170-179.
31. Hidaka H, Inagaki M, Kawamoto S, et al. Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C. Biochemistry. 1984;23:5036-5041.